Hims & Hers Health, INC Form 4 insider transactions

Hims & Hers Health, Inc. CFO, Oluyemi Okupe, executed stock option exercises and sales of Class A Common Stock under a pre-arranged 10b5-1 trading plan.

David B. Wells, a director at Hims & Hers Health, Inc., sold 40,000 shares of Class A Common Stock at an average price of $29.9896 on November 13, 2024.

Patrick Harrison Carroll, Chief Medical Officer of Hims & Hers Health, sold 4,707 shares of Class A Common Stock on November 11, 2024.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, sold 2,338 shares of Class A Common Stock at $26.46 per share on November 12, 2024, under a pre-arranged 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., exercised stock options and sold shares on November 11, 2024, according to a recent SEC filing.

Patrick Harrison Carroll, Chief Medical Officer and Director of Hims & Hers Health, Inc., sold 15,000 shares of Class A Common Stock at an average price of $22.0729 on November 6, 2024.

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock on November 5, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Chief Commercial Officer Michael Chi exercised stock options and sold shares of Hims & Hers Health, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,339 shares of Class A Common Stock at $23.16 per share under a pre-arranged 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,339 shares of Class A Common Stock at a price of $20.41 per share on October 15, 2024, under a pre-arranged 10b5-1 trading plan.

Irene Becklund, PAO of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on October 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. exercised stock options and sold shares on October 15, 2024, according to a recent SEC filing.

Oluyemi Okupe, CFO of Hims & Hers Health, executed stock option exercises and sales of Class A Common Stock on October 14, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Oluyemi Okupe, CFO of Hims & Hers Health, Inc., sold 9,868 shares of Class A Common Stock at an average price of $19.9627 on October 7, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock on October 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,339 shares of Class A Common Stock on October 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CFO Oluyemi Okupe exercised stock options and sold shares of Class A Common Stock on October 2, 2024, according to a Form 4 filing with the SEC.

Hims & Hers Health's CFO, Oluyemi Okupe, sold 12,651 shares of Class A Common Stock on September 20, 2024, at an average price of $16.7857 per share.

Hims & Hers Health CEO Andrew Dudum sold shares of Class A Common Stock on September 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., reports the vesting and disposal of restricted stock units to cover tax obligations.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.

Andrew Dudum, CEO of Hims & Hers Health, reports the vesting and tax withholding of restricted stock units, resulting in changes to his beneficial ownership.

Irene Becklund, PAO of Hims & Hers Health, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units, including transactions to cover tax obligations and sales under a 10b5-1 trading plan.

Director David B. Wells reports the vesting and conversion of Restricted Stock Units (RSUs) into Class A Common Stock.

Chief Medical Officer of Hims & Hers Health, Patrick Harrison Carroll, reports the vesting and sale of restricted stock units to cover tax obligations.

Chief Commercial Officer Michael Chi reports acquisition and disposal of Hims & Hers Health, Inc. Class A Common Stock and Restricted Stock Units.

Chief Financial Officer Oluyemi Okupe of Hims & Hers Health, Inc. reports the vesting and subsequent sale of Class A Common Stock to cover tax obligations.